Kamber, Nicole

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018

2024

Diem, L; Ovchinnikov, A; Friedli, C; Hammer, H; Kamber, N; Chan, A; Salmen, A; Findling, O; Hoepner, R (2024). Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: real-world experience of two Swiss Multiple Sclerosis centers. Multiple Sclerosis and Related Disorders, 86 Elsevier 10.1016/j.msard.2024.105570

2023

Léon Betancourt, Alejandro; Schwarzwald, Anina; Millonig, Alban; Oberholzer, Michael; Sabater, Lidia; Hammer, Helly; Kamber, Nicole; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke; Friedli, Christoph (2023). Anti-Kelch-like protein 11 (KLHL11) antibody associated encephalitis -Two case reports and review of the literature. European journal of neurology, 30(6), pp. 1801-1814. Wiley 10.1111/ene.15758

Schwarzwald, A; Salmen, A; Léon Betancourt, A; Diem, L; Hammer, H; Radojewski, P; Rebsamen, M; Kamber, N; Chan, A; Hoepner, R; Friedli, C (2023). Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia - a case report and review of the literature. European journal of neurology, 30(4), pp. 1135-1147. Wiley 10.1111/ene.15648

Kamber, Nicole; Chan, Andrew Hao-Kuang (March 2023). Schwerpunkt: Rheuma und Neurologie. Herangehensweise an Polyneuropathien – eine Übersicht. Rheuma Schweiz Fachzeitschrift

Friedli, Christoph; Wagner, Franca; Hammer, Helly Noemi; Kamber, Nicole; Wiest, Roland; Diem, Lara; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2023). Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients. Multiple sclerosis journal, 29(1), pp. 63-73. Sage 10.1177/13524585221122210

Friedli, Christoph; Salmen, Anke; Hoepner, Robert; Achtnichts, Lutz; Bigi, Sandra; Derfuss, Tobias; Gobbi, Claudio; Kamber, Nicole; Kamm, Christian P; Kuhle, Jens; Lalive, Patrice; Müller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Zecca, Chiara; Chan, Andrew (2023). Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022. Clinical and translational neuroscience, 7(1), p. 2. MDPI 10.3390/ctn7010002

2022

Diem, Lara; Schwarzwald, Anina; Friedli, Christoph; Hammer, Helly; Gomes-Fregolente, Livia; Warncke, Jan; Weber, Lea; Kamber, Nicole; Chan, Andrew; Bassetti, Claudio; Salmen, Anke; Hoepner, Robert (2022). Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS neuroscience & therapeutics, 28(12), pp. 1953-1963. Wiley 10.1111/cns.13938

Diem, L; Evangelopoulos, M E; Karathanassis, D; Natsis, V; Kamber, N; Hammer, H; Friedli, C; Chan, A; Helbling, A; Penner, I K; Salmen, A; Walther, S; Stegmayer, K; Hoepner, R (2022). Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue? Multiple Sclerosis and Related Disorders, 68, p. 104148. Elsevier 10.1016/j.msard.2022.104148

Hammer, H; Kamber, N; Pistor, M; Diem, L; Friedli, C; Chan, A; Hoepner, R; Salmen, A (2022). Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS). Multiple Sclerosis and Related Disorders, 65, p. 104015. Elsevier 10.1016/j.msard.2022.104015

Hammer, Helly; Kamber, Nicole; Friedli, Christoph; Hoepner, Robert; Diem, Lara; Chan, Andrew; Salmen, Anke (2022). [Primary CNS Vasculitis - An Overview]. Therapeutische Umschau. Revue therapeutique, 79(5), pp. 247-253. Huber 10.1024/0040-5930/a001358

Diem, Lara; Fregolente-Gomes, Livia; Warncke, Jan D; Hammer, Helly; Friedli, Christoph; Kamber, Nicole; Jung, Simon; Bigi, Sandra; Funke-Chambour, Manuela; Chan, Andrew; Bassetti, Claudio L; Salmen, Anke; Hoepner, Robert (2022). Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. Journal of central nervous system disease, 14, p. 11795735221102727. Sage 10.1177/11795735221102727

Hammer, H; Salmen, A; Kamber, N; Friedli, Chr; Diem, L; Hoepner, R; Chan, A (January 2022). Primäre ZNS-Vaskulitis. Rheuma Schweiz Fachzeitschrift, 2022(1), pp. 46-54.

Hammer, Helly; Hoepner, Robert; Friedli, Christoph; Leib, Stephen L; Suter-Riniker, Franziska; Diem, Lara; Kamber, Nicole; Chan, Andrew; Salmen, Anke; Kamm, Christian P (2022). Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines, 10(6), p. 922. MDPI 10.3390/vaccines10060922

Kamm, Christian P; Manjakunnel, Praveen; Lehnick, Dirk; Welter, Martin; Chan, Andrew; Kamber, Nicole; Vanbellingen, Tim (2022). From Diagnosis to Satisfaction in Multiple Sclerosis: A Swiss Patient Survey Highlighting the Importance of the First Diagnostic Consultation. Clinical and translational neuroscience, 6(1), p. 4. MDPI 10.3390/ctn6010004

2021

Rodriguez, Belén; Hoepner, Robert; Salmen, Anke; Kamber, Nicole; Z'Graggen, Werner J. (2021). Immunomodulatory treatment in postural tachycardia syndrome: A case series. European journal of neurology, 28(5), pp. 1692-1697. Wiley 10.1111/ene.14711

Veselaj, Krenar; Kamber, Nicole; Briner, Myriam; Friedli, Christoph; Diem, Lara; Guse, Kirsten; Miclea, Andrei; Wiest, Roland; Wagner, Franca; Grabe, Hilary; Abegg, Mathias; Horn, Michael P.; Bigi, Sandra; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2021). Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. CNS neuroscience & therapeutics, 27(4), pp. 426-438. Wiley 10.1111/cns.13461

Friedli, Christoph; Diem, Lara; Hammer, Helly; Kamber, Nicole; Suter-Riniker, Franziska; Leib, Stephen; Chan, Andrew; Hirzel, Cédric; Hoepner, Robert; Salmen, Anke (2021). Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. Therapeutic advances in neurological disorders, 14, p. 17562864211016641. Sage 10.1177/17562864211016641

2020

Kamber, Nicole (2020). [Neuroanatomy and Pathophysiology of Pain Perception]. Therapeutische Umschau, 77(6), pp. 239-245. Hogrefe 10.1024/0040-5930/a001185

2019

Miclea, Andrei; Salmen, Anke; Wiest, Roland; Zoehner, Greta; Wagner, Franca; Hoepner, Andreas; Schrewe, Lisa; Evangelopoulos, Maria-Eleptheria; Kamber, Nicole; Chan, Andrew Hao-Kuang; Hoepner, Robert (2019). Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study. Therapeutic advances in neurological disorders, 12, p. 1756286419835652. Sage 10.1177/1756286419835652

Achtnichts, Lutz; Chan, Andrew; Czaplinski, Adam; Derfuss, Tobias; Du Pasquier, Renaud; Findling, Oliver; Gobbi, Claudio; Hoepner, Robert; Kamber, Nicole; Kamm, Christian P.; Kuhle, Jens; Lalive, Patrice; Lutterotti, Andreas; Martin, Roland; Mller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Salmen, Anke; Schippling, Sven and Zecca, Chiara (2019). Besonderheiten der Immuntherapie der Multiplen Sklerose in der Schweiz. Swiss Medical Forum, 19(41-42), pp. 676-685. EMH Swiss Medical Publishers 10.4414/smf.2019.08356

Zoehner, Greta; Miclea, Andrei; Salmen, Anke; Kamber, Nicole; Diem, Lara; Friedli, Christoph; Bagnoud, Maud; Ahmadi, Farhad; Briner, Myriam; Sédille-Mostafaie, Nazanin; Kilidireas, Constantinos; Stefanis, Leonidas; Chan, Andrew; Hoepner, Robert; Evangelopoulos, Maria Eleftheria (2019). Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course. Therapeutic advances in neurological disorders, 12, p. 1756286419878340. Sage 10.1177/1756286419878340

Skorupka, Nic; Miclea, Andrei; Jalowiec, Katarzyna Aleksandra; Bocksrucker, Christoph; Kamber, Nicole; Chan, Andrew; Mansouri Taleghani, Behrouz; Hoepner, Robert; Salmen, Anke (2019). Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric Analysis. Transfusion medicine and hemotherapy, 46(6), pp. 417-422. Karger 10.1159/000504027

Kamber, Nicole; Chan, Andrew (2019). Multiple Sklerose. Länder-spezifische Aspekte der Indikation und Sicherheit aktueller Therapien. Info Neurologie & Psychiatrie, 17(20) Prime Public Media AG

Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073

2018

Scheidegger, Olivier; Kamber, Nicole; Rösler, Kai Michael (2018). Estimation of voluntary elicited motor neuron discharge using a peripheral nerve collision technique at different contraction strengths. Clinical neurophysiology, 129(8), pp. 1579-1587. Elsevier 10.1016/j.clinph.2018.04.751

Wagner, Franca; Grunder, Lorenz Nicolas; Hakim, Arsany; Kamber, Nicole; Horn, Michael; Müllner, Julia Nicole Maria; Hoepner, Robert; Wiest, Roland; Metz, Imke; Chan, Andrew; Salmen, Anke (2018). Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders. Frontiers in neurology, 9(782), p. 782. Frontiers Media S.A. 10.3389/fneur.2018.00782

Chan, Andrew; Kamber, Nicole; Hoepner, Robert; Salmen, Anke (2018). Fortschritte in der Therapie der Multiplen Sklerose. Therapeutische Umschau, 75(7), pp. 405-409. Huber 10.1024/0040-5930/a001016

Provide Feedback